Concepedia

Publication | Open Access

Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors

231

Citations

11

References

2017

Year

References

YearCitations

Page 1